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The Taiwan Association of Gynecology (TAG) hosted the 20th
Annual Meeting on Women's Health at the Taipei Veterans General
Hospital, Taipei, Taiwan, on September 13, 2015. There were three
prevailing themes, including (1) hormone therapy and medical
treatment for gynecologic diseases; (2) advanced surgery; and (3)
postmenopausal women. Over 200 attendees were present with
representation from ﬁve countries in Asia. Within this brief review,
we summarized the 12 plenary lectures.
Theme 1: Hormone therapy and medical treatment for
gynecologic diseases
In addition to improving survival, quality of life is another
important issue in the treatment of patients with gynecologic can-
cers. Quality of life is a multifactorial entity that encompasses sub-
jective perceptions of the positive and negative aspects of personal
experiences. Every element of quality of life, including physical
(e.g., pain, fatigue, disease symptoms, side effects of treatment, ac-
tivities of daily living, nutrition, sexuality, and so on), psychological
(e.g., body image, depression, anxiety, etc.), spiritual (e.g., religion,
meaning, hope, etc.), and social (e.g., family, community, income,
education, ethnicity, etc.), should all be taken into consideration
in the management of patients with gynecologic cancers. A recent
publication from the Taichung Veterans General Hospital empha-
sized the importance of consideration of quality of life. Two pa-
tients with primary adenoid cystic carcinomas of Bartholin's
glandwere treatedwith different strategies after primary conserva-
tive surgery, resulting in a signiﬁcant impact on quality of life. One
patient received adjuvant external-beam radiation and the other
received oral antiestrogen (tamoxifen) therapy. It is surprising
that external-beam radiation therapy did not provide a better sur-
vival beneﬁt, but impaired sexual function signiﬁcantly; by
contrast, oral antiestrogen therapy provided an adequate disease
control, and most importantly, the patient had a better quality of
life [1]. This lecture, provided by Dr Tze-Chien Chen (Mackay Me-
morial Hospital, Taipei, Taiwan), emphasized that therapy of
women with gynecologic cancers should be balanced by disease
control and quality of life.
Four speakers, including Professor Tasuku Harada (Tottori Uni-
versity Hospital, Tottori, Japan), Professor Ying-Fang Zhou (Peking
University First Hospital, Peking, China), Professor Jin-Hua Leng
(Peking Union Medical College Hospital, Peking, China), and Dr
Ting-Chen Chang (National Taiwan University Hospital, Taipei,
Taiwan), discussed the therapy of endometriosis and uterine ﬁ-
broids. Endometriosis, affecting 1e30% of women of reproductivehttp://dx.doi.org/10.1016/j.tjog.2015.10.022
1028-4559/Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Publishedage based on the different diagnostic criteria [2,3], is deﬁned by
the presence of viable, extrauterine, endometrial glands and
stroma, and is often considered as an estrogen-dependent disease
[4]. The treatment of endometriosis and its variants is surgical or
medical [5]. The use of laparoscopic surgery may be the most
effective method in dealing with and controlling endometriosis-
associated pain, and may be beneﬁcial in a certain populationd
women who have subfertility problems secondary to endometri-
osis. A recent meta-analysis showed that the use of laparoscopic
surgery in the treatment of subfertility related to minimal endo-
metriosis not only increases the pregnancy rate (relative risk of
1.44, 95% conﬁdence interval 1.24e1.68, p < 0.01), but also en-
hances the possibility of live birth (relative risk of 1.52, 95% conﬁ-
dence interval 1.26e1.84, p < 0.01) [6]. Although the possibility of
beneﬁcial effects of surgery in the management of endometriosis,
especially the use of laparoscopic cystectomy in the management
of ovarian endometrioma, has been reported, a certain percentage
of patients are refractory to surgery alone, and some of them have
a very high incidence of postoperative recurrence. In addition,
recently, it has been reported that cystectomy for ovarian endome-
trioma might have detrimental effects on ovarian reserve; espe-
cially for women undergoing repeated surgery, since stripping of
chocolate cyst lining may simultaneously remove normal tissues,
including intact follicles [7]. Therefore, medical treatment opin-
ions for endometriosis or uterine ﬁbroids may be the alternative
choice. The drugs for the management of endometriosis and its
variants, and uterine ﬁbroids include nonsteroidal anti-
inﬂammatory drugs, oral contraceptives, progestins, and
gonadotropin-releasing hormone agonist. Although the
gonadotropin-releasing hormone agonist exhibits considerable ef-
ﬁcacy by reducing the serum estradiol concentration to postmen-
opausal status, their agents are frequently accompanied by a high
incidence of hypoestrogenism-related symptoms and signs, which
might deteriorate women's health, including cardiovascular and
bone health, limiting the possibility of their long-term use. A
new type of drugs might be a good candidate for this purpose,
including a fourth generation of progestins and/or oral contracep-
tives. Dienogest, a 19-nortesterone derivative, has good oral
bioavailability and shows promising results in the management
of endometriosis-associated pain [8]. In fact, many hormone-
dependent gynecologic diseases, such as heavy menstrual
bleeding, dysmenorrhea, uterine leiomyomas, and endometriosis
and its variants, respond to hormone and/or antihormone therapy
[9]. Of most importance, these therapies could be used in the
augmentation or maintenance of therapeutic efﬁcacy after conser-
vative surgeries, especially for women who have a strong desire
for organ preservation [10,11]. Indications are that the currentby Elsevier Taiwan LLC. All rights reserved.
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gynecologic diseases, such as endometriosis and uterine ﬁbroid
and its variants, are to minimize the extensive tissue destruction
and repeated surgery by prescribing some candidate agents with
much more efﬁcacy and fewer side effects postoperatively [12].Theme 2: Advanced surgery
Four speakers reviewed the recently advanced surgery in the
management of women with gynecological diseases, including
two of the coauthors (Dr Chen and Dr Horng), Dr Elizabeth Joan
Esguerra-Ocampo (St. Luke's Medical Center, Global City, The
Philippines), and Dr Wen-Yih Wu (Far Eastern Memorial Hospital,
New Taipei City, Taiwan). The strategic planning of a scheduled
operation is crucial in the success of any surgery; therefore, thor-
ough patient evaluation is highly recommended to determine the
best approach to any gynecologic pathology [13]. Knowledge of
anatomy and physiology can make the surgery more efﬁcient
with less blood loss and rapid recovery, and fewer surgery-
related morbidity and possibly subsequent mortality. For example,
uterine-artery ligation might be a good alternative in the manage-
ment of various kinds of hemorrhage secondary to obstetric and gy-
necologic reasons [14]. In addition, although not widely practiced,
literature from more than 10 years ago suggests that instillation
of a liter of saline at the conclusion of laparoscopic gynecologic pro-
cedures could reduce shoulder pain [15,16]. Different specimen-
retrieval techniques should be known and patterned to speciﬁc pa-
thology to promote expeditious evacuation of a specimen, since the
physician is often concerned about the risk of port wound metasta-
ses and intraperitoneal spreading during laparoscopic gynecologic
surgeries [17,18]. Finally, with the help of a much more advanced
technology, such as robotic surgery, a single-port laparoscopy and
some anti-adhesive agents, and ﬁbrin sealant and hemostatic ma-
trix, surgery-related morbidity might be decreased [19,20]. Proﬁ-
ciency in all these factors can make gynecologic surgery look easy
and safe.Theme 3: Postmenopausal women
Menopause, although not a disease, is the biggest challenge for
clinical practice sincemenopausemay relate to many problems, not
only bothering women, but also deteriorating health and quality of
life. One of the coauthors (Dr Ho) and Professor Eu Leong Yong (Na-
tional University of Singapore and National University Hospital,
Singapore) addressed a talk about menopause and menopause-
related health problems. Osteoporosis, one of the most frequently
detected diseases in postmenopausal women, results in chronic
pain, fracture, and physical disability. The current treatment opin-
ions for osteoporosis include behavioral modiﬁcation, vitamin D
and/or calcium supplementation, selective estrogen-receptor mod-
ulators (raloxifene, the traditional Chinese medical plant Epime-
dium, etc. [21]), bisphosphonates, parathyroid hormones, and
antireceptor activator of nuclear factor-k B ligand antibody [22].
All are reported with a similar efﬁcacy in the management and/or
prevention of postmenopausal osteoporosis; however, physicians
should be familiar with adverse events, coexisting comorbidities,
and long-term adherence [23].
Pelvic organ prolapse, accompanied with and/or without uri-
nary problems, is also a commonly encountered women's health
issue, especially for postmenopausal women, with an incidence of
>40% [24]. During the past decade, interest has been growing in
uterus-preserving surgery worldwide, as shown previously [9,10].
Several surgical approaches with the aim of preserving the uterushave been developed, including sacral hysteropexy, uterosacral lig-
ament uterine suspension, and sacrospinous ligament uterine sus-
pension. In addition, the use of a transvaginal mesh with either
surgeon-tailored or commercial procedural kits is blossoming and
becoming popular in the ﬁeld [25,26]. However, its inﬂuence on
vaginal hysterectomies and the choice of surgeries for pelvic organ
prolapse remain unknown.
Conclusion
The TAG's 20th Annual Meeting on Women's Health was ended
on September 13, 2015. We appreciate all attendances and all hon-
orary speakers from Japan, Singapore, The Philippines, China, and
Taiwan who gave a comprehensive review addressing important
advances evident in several key areas shown previously, including
precision medicine, surgical innovation, and better patient care.
We encourage the audience to join the coming conference of the
TAG and the Taiwan Association of Obstetrics and Gynecology
next year.
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